Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-07-27

Clinical Trial Update: Duodenal Exclusion for the Treatment of Type 2 Diabetes [NA]

View source ↗

Summary

Medtronic-sponsored trial of duodenal exclusion for Type 2 diabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duodenal exclusion device

Snippet

Sponsor: Medtronic - MITG | Conditions: Diabetes | NA | Status: WITHDRAWN